Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Kamakshi Sivaramakrishnan Joins LiveRamp Board of Directors : https://mms.businesswire.com/media/20191105005799/en/754502/5/Source-Logo-300.jpg
Kamakshi Sivaramakrishnan Joins LiveRamp Board of Directors


LiveRamp® (NYSE: RAMP), the leading data connectivity platform, today announced the appointment of Kamakshi Sivaramakrishnan to its board of directors. Previously the CEO and co-founder of

Charles River Laboratories to Present at Upcoming Investor Conferences: https://mms.businesswire.com/media/20191106005189/en/754630/5/charles_river_logo.jpg
Charles River Laboratories to Present at Upcoming Investor Conferences


Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at three upcoming investor conferences, including:




  • Credit Suisse 29th Annual Virtual

Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the SITC Annual Meeting: https://mms.businesswire.com/media/20191105006084/en/713581/5/Xencor_RGB_fullcolor.jpg
Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the SITC Annual Meeting


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced the

Xencor Presents Updated Data From the DUET-2 Phase 1 Study of XmAb20717, PD-1 x CTLA-4 Bispecific Antibody, at the SITC Annual Meeting: https://mms.businesswire.com/media/20191105006084/en/713581/5/Xencor_RGB_fullcolor.jpg
Xencor Presents Updated Data From the DUET-2 Phase 1 Study of XmAb20717, PD-1 x CTLA-4 Bispecific Antibody, at the SITC Annual Meeting


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today reported data from its

EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against Viral S1 Protein: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24701/263px-PerkinElmer.svg.png
EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against Viral S1 Protein


PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that EUROIMMUN, a PerkinElmer company, has launched the Anti-SARS-CoV-2 QuantiVacTM

COPT to Present at Nareit’s REITworld: 2020 Virtual Annual Conference: https://mms.businesswire.com/media/20191107006031/en/58018/5/COPT_2ColorRGB.jpg
COPT to Present at Nareit’s REITworld: 2020 Virtual Annual Conference


Corporate Office Properties Trust (“COPT” or the “Company”) (NYSE: OFC) announced that its President and CEO, Stephen E. Budorick, will provide an update on the Company and participate in a

Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2020 Earnings Release and Conference Call: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2020 Earnings Release and Conference Call


Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its fourth quarter and full year financial results for fiscal year 2020, ended August 31, 2020, after the close of the

Madison Square Garden Sports Corp. Reports Fiscal 2021 First Quarter Results: https://mms.businesswire.com/media/20201106005470/en/836696/5/MSGS_Logo.jpg
Madison Square Garden Sports Corp. Reports Fiscal 2021 First Quarter Results


Madison Square Garden Sports Corp. (NYSE: MSGS) today reported financial results for the fiscal first quarter ended September 30, 2020.



Results for the fiscal 2021 first quarter reflect the

IMV’s T Cell Therapy Demonstrates 86% Objective Response Rate in Combination with Merck’s Keytruda® in PD-L1 Positive Patients with r/r DLBCL: https://mms.businesswire.com/media/20200225005324/en/775456/5/IMV_Logos_IMV-Logo_BrandStatement.jpg
IMV’s T Cell Therapy Demonstrates 86% Objective Response Rate in Combination with Merck’s Keytruda® in PD-L1 Positive Patients with r/r DLBCL


IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced that the Company’s T cell therapy demonstrates an 86%

Sassy Resources Lists on Frankfurt Stock Exchange; Engages European Investor Relations; Revises Final Private Placement Total to $4.5m
Sassy Resources Lists on Frankfurt Stock Exchange; Engages European Investor Relations; Revises Final Private Placement Total to $4.5m

VANCOUVER, British Columbia, November 9, 2020 - Sassy Resources Corporation (“Sassy” or the “Company”) (CSE: SASY) (FSE: 4E7) is pleased to announce the listing of its common shares for

Novocure Announces Closing of $150 Million Revolving Credit Facility with a Syndicate of Relationship Banks: https://mms.businesswire.com/media/20191120005453/en/721126/5/novocure_main%405x.jpg
Novocure Announces Closing of $150 Million Revolving Credit Facility with a Syndicate of Relationship Banks


Novocure (NASDAQ: NVCR), a global oncology company working to extend survival in some of the most aggressive forms of cancer, today announced the closing of a new $150 million senior secured

Kodiak Drills 192 m of 0.74% Copper and 0.48 g/t Gold (1.21% CuEq*), Within 515.8 m of 0.41% Copper and 0.22 g/t Gold (0.63% CuEq*)
Kodiak Drills 192 m of 0.74% Copper and 0.48 g/t Gold (1.21% CuEq*), Within 515.8 m of 0.41% Copper and 0.22 g/t Gold (0.63% CuEq*)

November 9, 2020 – Vancouver, British Columbia – Kodiak Copper Corp. (the "Company" orKodiak”) (TSX-V: KDK) today reports further drill results from the Gate Zone from its ongoing fully

GE Healthcare, GenesisCare Partner to Tackle Two Biggest Health Burdens Globally, Deliver Improved Cancer and Cardiovascular Care to Patients Around the World
GE Healthcare, GenesisCare Partner to Tackle Two Biggest Health Burdens Globally, Deliver Improved Cancer and Cardiovascular Care to Patients Around the World


GE Healthcare, the leading global provider of advanced medical imaging, and GenesisCare, a leading provider of integrated cancer care globally and cardiovascular care in Australia, today announced

CORRECTING and REPLACING Cushman & Wakefield Acquires Substantially All of the Assets of Triad Commercial Properties in North Carolina
CORRECTING and REPLACING Cushman & Wakefield Acquires Substantially All of the Assets of Triad Commercial Properties in North Carolina


Headline of release should read: Cushman & Wakefield Acquires Substantially All of the Assets of Triad Commercial Properties in North Carolina (instead of Cushman & Wakefield Acquires Triad

Howmet Aerospace Reports Third Quarter 2020 Financial Resultshttp://dwellinguptocanberra2012.com/files/2012/06/imagesCAOAPEO3-plnztx.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/11082/imagesCAOAPEO3-plnztx.jpg
Howmet Aerospace Reports Third Quarter 2020 Financial Results


On April 1, 2020, Arconic Inc. completed the separation of its business into two independent, publicly-traded companies: Howmet Aerospace Inc. (the new name for Arconic Inc.) and Arconic

Lomiko Encouraged by President-Elect Biden’s $400 Billion Clean Energy Plan
Lomiko Encouraged by President-Elect Biden’s $400 Billion Clean Energy Plan

(Vancouver, Canada November 9, 2020) Lomiko Metals Inc. (“Lomiko”) (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) is focused on the exploration and development of flake graphite in Quebec for the new

Fury Commences 50,000 Metre Drill Program at Eau Claire Project in Quebec
Fury Commences 50,000 Metre Drill Program at Eau Claire Project in Quebec

 

Vancouver and Toronto, Canada – November 9, 2020 – Fury Gold Mines Limited (TSX: FURY, NYSE American: FURY) (“Fury” or the “Company” - https://www.commodity-tv.com/play/fury-gold-mines-star

Lindsay Corporation to Discuss Key Innovation Strategies at Virtual Investor Event
Lindsay Corporation to Discuss Key Innovation Strategies at Virtual Investor Event


Lindsay Corporation (NYSE: LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, today announced that it will host a Virtual Investor Event

 Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study
 Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study


Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in

IMC International Mining Corp. To Release Results From Thane Property Work Program and Provides Corporate Update
IMC International Mining Corp. To Release Results From Thane Property Work Program and Provides Corporate Update

November 9, 2020 - Vancouver, BC – IMC International Mining Corp. (CSE:IMCX) (OTC:IMIMF) (FRA:3MX) (the “Company” or “IMC”), is pleased to advise that the results of the Thane Property summer

NTT DATA Germany and NICE Forge Strategic Partnership to Improve Customer Experiences and Drive Cloud Transformations with CXone: https://mms.businesswire.com/media/20191203005409/en/615391/5/NICE_inContact.jpg
NTT DATA Germany and NICE Forge Strategic Partnership to Improve Customer Experiences and Drive Cloud Transformations with CXone


NICE (Nasdaq: NICE) today announced a strategic partnership with NTT DATA Germany a leading Business-and IT-solution provider. The aim of the partnership is to jointly provide a broad portfolio of

Cannae Holdings, Inc. Announces Third Quarter 2020 Financial Results
Cannae Holdings, Inc. Announces Third Quarter 2020 Financial Results


Cannae Holdings, Inc. (NYSE:CNNE) (“Cannae” or the “Company”) has released its third quarter 2020 financial results by posting them to its website. Please visit the Cannae investor relations

PotlatchDeltic Appoints Eric J. Cremers President and Chief Executive Officer and Names Michael J. Covey Executive Chairperson
PotlatchDeltic Appoints Eric J. Cremers President and Chief Executive Officer and Names Michael J. Covey Executive Chairperson


(NASDAQ: PCH) PotlatchDeltic Corporation’s board of directors today announced that Eric J. Cremers, currently the company’s president and chief operating officer, has been appointed president and

NanoString Launches GeoMx DSP Protein Assays for Next Generation Sequencing: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString Launches GeoMx DSP Protein Assays for Next Generation Sequencing


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of GeoMx® DSP Protein Assays for next

ALLETE, Inc. Reports Third Quarter Earnings of 78 Cents: https://mms.businesswire.com/media/20191210005166/en/401334/5/Ace_logo.jpg
ALLETE, Inc. Reports Third Quarter Earnings of 78 Cents


ALLETE, Inc. (NYSE: ALE) today reported third quarter 2020 earnings of 78 cents per share on net income of $40.7 million. Last year’s results were 60 cents per share on net income of $31.2 million